Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

This is Dermata's first issued U.S. patent for XYNGARI, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI clini ...

This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne - - Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...

Struggling with shoulder pain and stiffness that makes everyday tasks like reaching or dressing difficult? You may be dealing ...

Ginger’s anti-inflammatory and antioxidant properties can help with acne reduction. Check out how to make and consume ginger ...

Hard water is unavoidable for many but can cause hair breakage, colour-fade and dry skin. Read on for the best advice and ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 . SHENZHEN, CHINA, Jan 24, 2025 - (ACN News ...

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

• Topical treatments: Over-the-counter 1% hydrocortisone cream can help with mild flare-ups. For more severe cases, pediatricians may prescribe stronger topical steroids or calcineurin inhibitors.